Dr. Rodriguez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8116 Vailview Cove
Austin, TX 78750- Is this information wrong?
Education & Training
Baylor College of MedicinePost-Doctoral Fellowship, Komen for the Cure Multidisciplinary Breast Cancer Fellowship, 2007 - 2009- Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008
- Baylor College of MedicineResidency, Internal Medicine, 2002 - 2005
Universidad Central del Caribe School of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2004 - 2024
Clinical Trials
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsTreatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report.Georges Azzi, Shifra Krinshpun, Antony Tin, Minu Maninder, Allyson Koyen Malashevich, Meenakshi Malhotra, Ruben Ruiz Vega, Paul R Billings, Angel Rodriguez, Alexey Ale...> ;Case Reports in Oncology. 2022 May 2
- 30 citationsImpact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors.Pashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, Naureen Starling, Yoshiaki Nakamura, Daisuke Kotani, Thomas Powles, Bob T Li, Lajos Pusztai, Vasily N Aushev, Ekat...> ;JCO Precision Oncology. 2022 Mar 1
- 38 citationsA phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.Andrew W Chung, Kartik Anand, Ann C Anselme, Alfred A Chan, Nakul Gupta, Luz A Venta, Mary R Schwartz, Wei Qian, Yitian Xu, Licheng Zhang, John Kuhn, Tejal Patel, Ange...> ;Science Translational Medicine. 2021 Dec 15
- Join now to see all
Press Mentions
Catching Cancer Red-HandedDecember 1st, 2021
Drug That Improves Blood Flow in Damaged Heart Might Also Fight Breast CancerJanuary 6th, 2017
Hospital Affiliations
Ascension Seton Medical Center AustinAustin, Texas
St. David's Medical CenterAustin, Texas
Kindred Hospital Houston Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
